Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients
This is a research study to evaluate change in Quality of Life, as defined by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC C-30), from baseline to 1 month post treatment in two patient cohorts receiving Interventional Radiology Liver Directed Therapies or Hypofractionated Image-Guided Radiation Therapy.
Liver Cancer
OTHER: Quality of life questionnaires
change in quality of life in patient cohorts receiving either Interventional Radiology Liver Directed Therapies or Hypofractionated Image-Guided Radiation Therapy, as defined by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC C-30) measured from not at all (better) to very much (worse), baseline, 1 month, 3 months, 6 months
change in quality of life in patients receiving Interventional Radiology Liver Directed Therapies or HIGRT, as measured by the FACT-Hep survey questionnaire from not at all (better) to very much (worse), baseline, 1 month, 3 months, 6 months|number of patients with grade ≥2 acute toxicity that received Interventional Liver Directed Therapy, 90 days|number of patients with grade ≥2 acute toxicity that received Hypofractionated Image Guided Radiation Therapy, 90 days|total healthcare system cost associated with Interventional Radiology Liver Directed Therapies, 90 days|total healthcare system cost associated with Hypofractionated Liver Directed Therapy, 90 days
This is a research study to evaluate change in Quality of Life, as defined by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC C-30), from baseline to 1 month post treatment in two patient cohorts receiving Interventional Radiology Liver Directed Therapies or Hypofractionated Image-Guided Radiation Therapy.